KLG Stock +78.58% In 3 Months Since We Picked It KLG Stock +78.58% In 3 Months Since We Picked It Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Axcella Health Inc. Stock and on which exchange is it traded?
The symbol for Axcella Health Inc. is AXLA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Axcella Health Inc. Stock?
Axcella Health Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Axcella Health Inc. Stock?
Axcella Health Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Axcella Health Inc. Stock.

What's the current price of Axcella Health Inc. Stock?
As of the end of day on the Mar 28, 2024, the price of an Axcella Health Inc. (AXLA) share was $0.401.

What is the 52-week high and low for Axcella Health Inc. Stock?
The 52-week high for Axcella Health Inc. Stock is $41.25 and the 52-week low is $0.340.

What is the market capitalization of Axcella Health Inc. Stock?
As of the Mar 28, 2024, the market capitalization of Axcella Health Inc. is 1.182M.

When is the next earnings date for Axcella Health Inc.?
The upcoming earnings date for Axcella Health Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Axcella Health Inc.

Axcella Health. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well a... AXLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT